CLOs on the Move

Diamedica

www.diamedica.com

 
DiaMedica Inc., a development stage biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of diabetes and related diseases. The company`s lead clinical stage compound is DM199, a recombinant human protein known as rhKLK1, which is under phase I/II clinical trials for the treatment of Type 1 and Type 2 diabetes and associated complications. It is also developing DM204, a monoclonal antibody that is in preclinical development for the treatment of Type 2 diabetes; and DMDx, a chronic kidney disease assay to detect levels of the tissue kallikrein-1 protein in urine and to predict the ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.diamedica.com
  • Two Carlson Parkway Suite 260
    Minneapolis, MN USA 55447
  • Phone: 763.496.5454

Executives

Name Title Contact Details

Similar Companies

TMS International

TMSi is specialized in developing of high-quality measurement systems for electrophysiological parameters such as EEG and High Density EMG. Our systems are highly versatile and have the best data quality possible.

Wallace Pharmaceuticals

Wallace Pharmaceuticals is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Center for Autism and Related Disorders

The Center for Autism and Related Disorders, Inc.

Genexa

Genexa is the world`s first and only clean medicine company and was recognized in 2022 by Fast Company as the no. 1 Most Innovative Company in Wellness. We were founded in 2016 by two dads who believed medicine should only have the active ingredients you need, and not the artificial fillers you don`t. It`s medicine made clean, because that`s what people deserve. Our headquarters is located in Atlanta, where we strive to put people over everything

CardioRisk

CardioRisk is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.